imValv is a leading startup company in treating and managing glaucoma with cutting -edge patented technology combination of intelligent micromachines, internet of things
and Big Data. Better treatment, patient monitoring, less cost, avoiding retreatment,
and mini mally-invasiveness management avoiding cumbersome lifetime conventional
treatment of medical drops and big or passive valves and shunts.
We hope to capture a global market valued at USD 1B and to prevent blindness in
+70M.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Av Belgrano 758, Sunchales,santa Fe 2322,argentina
- Industry
- Nanotechnology Research
- NAICS
-
Research and Development in Nanotechnology
- Website
- https://twitter.com/imvalv
- Keywords
- Ophthalmology, Medical Devices, Intraocular Pressure, Glaucoma, MEMS, Internet of Things, Wireless.
- HQ
- Sunchales, Santa Fe
- Competitors
- PhylumTech, epiliquid, CITES, Bloq Capital, Loci Labs.
Imvalv Questions
Imvalv's website is https://twitter.com/imvalv
Imvalv's LinkedIn profile is https://ar.linkedin.com/company/imvalv
Imvalv has
2 employees.
View email and phone details for 2
employees at Imvalv.
Imvalv's industry is
Nanotechnology Research
Imvalv's categories are Nanotechnology Research
Imvalv's founding year is 2017
